SURGE Therapeutics Raises $32M Series B Financing
19 Jul 2023 //
BUSINESSWIRE
SURGE Receives FDA Clearance to Initiate Ph1/2a of Intraoperative Immunotherapy
04 Jan 2023 //
BUSINESSWIRE
19 Jul 2023 //
BUSINESSWIRE
04 Jan 2023 //
BUSINESSWIRE